Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reductions in the white-gray functional connectome in preclinical Alzheimer's disease and their associations with amyloid and cognition.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2024

Same author

White matter engagement in brain networks assessed by integration of functional and structural connectivity.

NeuroImage·2024

Same author

Layer-specific BOLD effects in gradient and spin-echo acquisitions in somatosensory cortex.

Magnetic resonance in medicine·2024

Same author

AI-assisted 3D analysis of grasping and reaching behavior of squirrel monkeys during recovery from cervical spinal cord injury.

Behavioural brain research·2024

Same author

Restriction-induced time-dependent transcytolemmal water exchange: Revisiting the Kӓrger exchange model.

Journal of magnetic resonance (San Diego, Calif. : 1997)·2024

Same author

Functional correlation tensors in brain white matter and the effects of normal aging.

Brain imaging and behavior·2024

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Molecular imaging without radiopharmaceuticals?

John C Gore¹, Thomas E Yankeelov, Todd E Peterson

¹Institute of Imaging Science, Vanderbilt University, Nashville, Tennessee 37232-2310, USA. john.gore@vanderbilt.edu

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine

|May 16, 2009

Summary

This summary is machine-generated.

Molecular imaging shows promise for MRI, CT, and ultrasound using targeted contrast agents. Large carrier systems like particles and bubbles can enhance detection sensitivity for these imaging techniques.

More Related Videos

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

Related Experiment Videos

Last Updated: Jun 23, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

Area of Science:

Medical Imaging
Biophysics
Nanotechnology

Background:

Current imaging modalities like MRI, CT, and ultrasound have sensitivity limitations for detecting molecular processes.
Radionuclear methods offer higher sensitivity for molecular detection, but face challenges in targeted agent delivery for specific applications.
Existing contrast agents for conventional imaging may not suffice for sensitive molecular imaging.

Purpose of the Study:

To evaluate the practical requirements and feasibility of molecular imaging using MRI, CT, and ultrasound.
To assess the potential of targeted contrast enhancement for improving sensitivity in these modalities.
To explore strategies for overcoming sensitivity limitations in molecular imaging.

Main Methods:

Analysis of sensitivity limitations in MRI, CT, and ultrasound pulse-echo imaging.
Theoretical considerations for targeted contrast agent delivery using carrier systems (particles, liposomes, bubbles).
Evaluation of higher-resolution imaging techniques and advanced X-ray sources (monochromatic X-rays).

Main Results:

Molecular imaging with MRI, CT, and ultrasound is unlikely to match radionuclear method sensitivity for all applications.
Large carrier systems (particles, liposomes) can deliver sufficient paramagnetic agents for detectable MR signal changes.
Higher-resolution MRI aids molecular imaging in small animals.
Large particles or carriers of high atomic number materials show potential for CT, especially with monochromatic X-rays.
Gas-filled bubbles offer detectable ultrasound contrast at practical concentrations.

Conclusions:

Molecular imaging using MRI, CT, and ultrasound is feasible with advanced strategies, particularly for specific applications.
Carrier systems are crucial for achieving adequate concentrations of contrast agents for MRI and CT.
Ultrasound molecular imaging is viable using gas-filled bubbles as contrast agents.
The prospects for molecular imaging with X-ray techniques are more promising than previously thought.